# Olema Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed May 13, 2025

- Company: [Olema Pharmaceuticals, Inc.](/companies/olma.md) (CIK 1750284)
- Form: SCHEDULE 13D/A
- Filed: 2025-05-13
- Accepted by EDGAR: May 13, 2025, 23:29 ET
- Period: not reported
- Accession: 0000935836-25-000324
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1750284/000093583625000324/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750284/000093583625000324/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750284/000093583625000324/xslSCHEDULE_13D_X01/primary_doc.xml

Filed May 13, 2025.
Source: SEC EDGAR, the filing index for accession 0000935836-25-000324. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.